跳到正文

BeyondSpring Inc.（BYSI）内部人交易：高管与董事近期交易

过去 18 个月，共有 8 位内部人为 BeyondSpring Inc.（BYSI）报告了 393 笔 Form 4 交易（最近一笔 2026-05-15）。

日期内部人职务类型股数市值
2026-05-15Huang LanChief Executive Officer卖出260,582$0
2025-10-20Decheng Capital China Life Sciences USD Fund II, L.P.10% 以上股东卖出45,513$80,103
2025-10-20Decheng Capital China Life Sciences USD Fund II, L.P.10% 以上股东卖出85,798$147,573
2025-10-20Decheng Capital China Life Sciences USD Fund III, L.P.10% 以上股东卖出85,798$147,573
2025-10-20Decheng Capital Management III (Cayman), LLC10% 以上股东卖出85,798$147,573
2025-10-20Decheng Capital Global Healthcare Fund (Master), LP10% 以上股东卖出85,798$147,573
2025-10-20Decheng Capital Global Healthcare GP, LLC10% 以上股东卖出85,798$147,573
2025-10-20Decheng Capital Management II (Cayman), LLC10% 以上股东卖出85,798$147,573
2025-10-20Cui Xiangmin10% 以上股东卖出45,513$80,103
2025-10-20Decheng Capital China Life Sciences USD Fund III, L.P.10% 以上股东卖出45,513$80,103
2025-10-20Decheng Capital Management III (Cayman), LLC10% 以上股东卖出45,513$80,103
2025-10-20Decheng Capital Global Healthcare Fund (Master), LP10% 以上股东卖出45,513$80,103
2025-10-20Decheng Capital Global Healthcare GP, LLC10% 以上股东卖出45,513$80,103
2025-10-20Decheng Capital Management II (Cayman), LLC10% 以上股东卖出45,513$80,103
2025-10-20Cui Xiangmin10% 以上股东卖出85,798$147,573
2025-10-15Decheng Capital China Life Sciences USD Fund III, L.P.10% 以上股东卖出28,495$47,017
2025-10-15Cui Xiangmin10% 以上股东卖出107,361$182,514
2025-10-15Decheng Capital China Life Sciences USD Fund II, L.P.10% 以上股东卖出107,361$182,514
2025-10-15Decheng Capital China Life Sciences USD Fund III, L.P.10% 以上股东卖出107,361$182,514
2025-10-15Decheng Capital Management III (Cayman), LLC10% 以上股东卖出107,361$182,514
2025-10-15Decheng Capital Global Healthcare Fund (Master), LP10% 以上股东卖出107,361$182,514
2025-10-15Decheng Capital Global Healthcare GP, LLC10% 以上股东卖出107,361$182,514
2025-10-15Decheng Capital Management II (Cayman), LLC10% 以上股东卖出107,361$182,514
2025-10-15Cui Xiangmin10% 以上股东卖出28,495$47,017
2025-10-15Decheng Capital China Life Sciences USD Fund II, L.P.10% 以上股东卖出28,495$47,017

来源：SEC Form 4 申报文件 · 截至 2026-05-15